Sarepta Therapeutics | الأصول



Assets تغيير تاريخ
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amgen USD 87.9B 1.47B 2025-06
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Daiichi Sankyo JPY 3.46T 3.5B 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
Incyte USD 5.82B 71.99M 2025-06
Insmed USD 2.48B 677.12M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
Moderna USD 12.01B 694M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Pfizer USD 206.1B 1.93B 2025-06
PTC Therapeutics USD 2.63B 21.23M 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 124.96B 6.93B 2025-06
Sarepta Therapeutics USD 3.68B 214.43M 2025-06
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
Ultragenyx Pharmaceutical USD 1.31B 5.66M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


Sarepta Therapeutics الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.